Publications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (6)

2024

  1. In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma

    Cell Reports Medicine, Vol. 5, Núm. 8

  2. RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade

    Nature Communications, Vol. 15, Núm. 1

2021

  1. Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer

    Trends in Cancer, Vol. 7, Núm. 5, pp. 410-429

2020

  1. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma

    JCI Insight, Vol. 5, Núm. 15

2016

  1. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma

    Nature Medicine, Vol. 22, Núm. 3, pp. 270-277

2014

  1. Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts

    Cancer Research, Vol. 74, Núm. 21, pp. 5978-5988